Effect compartment equilibration and time-to-peak effect. Importance of a pharmacokinetic-pharmacodynamic principle for the daily clinical practice;Wirkortäquilibration, anschlagzeit, "time to peak effect". Bedeutung pharmakokinetisch-dynamischer prinzipien für die tägliche klinische praxis

Anaesthesist

Volumn 54, Issue 10, 2005, Pages 1021-1031

  Bruhn, J ^a   Schumacher, P M ^b   Bouillon, T W ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Effect compartment equilibration; Effect site compartment; Pharmacokinetics; Respiratory depression; Target controlled infusion (TCI) systems; Time to peak effect

Indexed keywords

ALFENTANIL; ANESTHETIC AGENT; ATRACURIUM; DESFLURANE; ETOMIDATE; FENTANYL; ISOFLURANE; MIDAZOLAM; MIVACURIUM; MUSCLE RELAXANT AGENT; PANCURONIUM; PIRITRAMIDE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUFENTANIL; SUXAMETHONIUM; THIOPENTAL; VECURONIUM;

ANESTHESIA; ANESTHESIST; ARTICLE; BLOOD LEVEL; BREATHING; CLINICAL PRACTICE; COMPARATIVE STUDY; COMPREHENSION; DRUG EFFICACY; DRUG SAFETY; HUMAN; MEDICAL ERROR; MUSCLE RELAXATION;

ALGORITHMS; ANESTHESIA; ANESTHETICS; ANIMALS; DRUG DELIVERY SYSTEMS; HALF-LIFE; HUMANS; INFUSIONS, INTRAVENOUS;

EID: 27644473110     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-005-0864-8     Document Type: Article

References (44)

1. Billard V, Gambus PL, Chamoun N et al. (1997) A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect. Clin Pharmacol Ther 61:45-58
2. Bouillon T, Schmidt C, Garstka G et al. (1999) Pharmacokinetic- pharmacodynamic modeling of the respiratory depressant effect of alfentanil. Anesthesiology 91:144-155
3. Bouillon T, Bruhn J, Radu-Radulescu L et al. (2003) A model of the ventilatory depressant potency of remifentanil in the non-steady state. Anesthesiology 99:779-787
4. Bouillon T, Garstka G, Stafforst D et al. (2003) Piritramide and alfentanil display similar respiratory depressant potency. Acta Anaesthesiol Scand 47:1231-1241
5. Bouillon T, Bruhn J, Radu-Radulescu L et al. (2004) Mixed-effects modeling of the intrinsic ventilatory depressant potency of propofol in the non-steady state. Anesthesiology 100:240-250
6. Bruhn J, Ropcke H, Hoeft A (2000) Approximate entropy as an electroencephalographic measure of anesthetic drug effect during desflurane anesthesia. Anesthesiology 92:715-726
7. Buhrer M, Maitre PO, Crevoisier C et al. (1990) Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam. Clin Pharmacol Ther 48:555-567
8. Coetzee JF, Glen JB, Wium CA et al. (1995) Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets. Anesthesiology 82:1328-1345
9. Donati F, Varin F, Ducharme J et al. (1991) Pharmacokinetics and pharmacodynamics of atracurium obtained with arterial and venous blood samples. Clin Pharmacol Ther 49:515-522
10. Doufas AG, Bakhshandeh M, Bjorksten AR et al. (2004) Induction speed is not a determinant of propofol pharmacodynamics. Anesthesiology 101:1112-1121
11. Dragne A, Varin F, Plaud B et al. (2002) Rocuronium pharmacokinetic- pharmacodynamic relationship under stable propofol or isoflurane anesthesia. Can J Anaesth 49:353-360
12. Egan TD, Minto CF, Hermann DJ et al. (1996) Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 84:821-833
13. Ekman A, Lindholm ML, Lennmarken C et al. (2004) Reduction in the incidence of awareness using BIS monitoring. Acta Anaesthesiol Scand 48:20-26
14. Fechner J, Albrecht S, Ihmsen H et al. (1998) Prädiktivitat und Präzision einer "target-controlled infusion" (TCI) von Propofol mit dem System "Disoprifusor TCI". Anaesthesist 47:663-668
15. Gepts E, Camu F, Cockshott ID et al. (1987) Disposition of propofol administered as constant rate intravenous infusions in humans. Anesth Analg 66:1256-1263
16. Heidegger T, Minto CF, Schnider TW (2004) Moderne Konzepte der Pharmakokinetik intravenöser Anasthetika. Anaesthesist 53:95-110
17. Hull CJ, Beem HB van, McLeod K et al. (1978) A pharmacodynamic model for pancuronium. Br J Anaesth 50:1113-1123
18. Ihmsen H, Jeleazcov C, Schuttler J et al. (2004) Präzision von "target-controlled infusion" (TCI) mit zwei unterschiedlichen Propofolformulierungen. Anaesthesist 53:937-943
19. Johnson KB, Egan TD, Layman J et al. (2003) The influence of hemorrhagic shock on etomidate: a pharmacokinetic and pharmacodynamic analysis. Anesth Analg 96:1360-1368, table
20. Kietzmann D, Bouillon T, Hamm C et al. (1997) Pharmacodynamic modelling of the analgesic effects of piritramide in postoperative patients. Acta Anaesthesiol Scand 41:888-894
21. Koh KF, Chen FG (1994) Rapid tracheal intubation with atracurium: the timing principle. Can J Anaesth 41:688-693
22. Kreuer S, Wilhelm W, Grundmann U et al. (2004) Narcotrend index versus bispectral index as electroencephalogram measures of anesthetic drug effect during propofol anesthesia. Anesth Analg 98:692-697, table
23. Laurin J, Donati F, Nekka F et al. (2001) Peripheral link model as an alternative for pharmacokinetic-pharmacodynamic modeling of drugs having a very short elimination half-life. J Pharmacokinet Pharmacodyn 28:7-25
24. Li YH, Xu JH, Yang JJ et al. (2005) Predictive performance of "Diprifusor" TCI system in patients during upper abdominal surgery under propofol/fentanyl anesthesia. J Zhejiang Univ Sci 6:43-48
25. Lim TA (2003) A novel method of deriving the effect compartment equilibrium rate constant for propofol. Br J Anaesth 91:730-732
26. Maitre PO, Buhrer M, Shafer SL et al. (1990) Estimating the rate of thiopental blood-brain equilibration using pseudo steady state serum concentrations. J Pharmacokinet Biopharm 18:175-187
27. Marathe PH, Dwersteg JF, Pavlin EG et al. (1989) Effect of thermal injury on the pharmacokinetics and pharmacodynamics of atracurium in humans. Anesthesiology 70:752-755
28. Marsh B, White M, Morton N et al. (1991) Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 67:41-48
29. Minto CF, Schnider TW, Egan TD et al. (1997) Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 86:10-23
30. Minto CF, Schnider TW, Gregg KM et al. (2003) Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics. Anesthesiology 99:324-333
31. Rehberg B, Bouillon T, Zinserling J et al. (1999) Comparative pharmacodynamic modeling of the electroencephalography-slowing effect of isoflurane, sevoflurane, and desflurane. Anesthesiology 91:397-405
32. Renz D (2002) Das MEC Konzept: Ein optimiertes Dosierungsverfahren der TCI-Technologie. B. Braun Melsungen AG, Melsungen
33. Roy JJ, Donati F, Boismenu D et al. (2002) Concentration-effect relation of succinylcholine chloride during propofol anesthesia. Anesthesiology 97:1082-1092
34. Schnider TW, Minto CF, Gambus PL et al. (1998) The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 88:1170-1182
35. Schnider TW, Minto CF, Shafer SL et al. (1999) The influence of age on propofol pharmacodynamics. Anesthesiology 90:1502-1516
36. Scott JC, Stanski DR (1987) Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 240:159-166
37. Scott JC, Cooke JE, Stanski DR (1991) Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 74:34-42
38. Sebel PS, Lang E, Rampil IJ et al. (1997) A multicenter study of bispectral electroencephalogram analysis for monitoring anesthetic effect. Anesth Analg 84:891-899
39. Sheiner LB, Stanski DR, Vozeh S et al. (1979) Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 25:358-371
40. Sohn YJ, Bencini AF, Scaf AH et al. (1986) Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients. Anesth Analg 65:233-239
41. Struys MM, Smet T de, Depoorter B et al. (2000) Comparison of plasma compartment versus two methods for effect compartment - Controlled target-controlled infusion for propofol. Anesthesiology 92:399-406
42. Vuyk J, Engbers FH, Burm AG et al. (1995) Performance of computer-controlled infusion of propofol: an evaluation of five pharmacokinetic parameter sets. Anesth Analg 81:1275-1282
43. White M, Schenkels MJ, Engbers FH et al. (1999) Effect-site modelling of propofol using auditory evoked potentials. Br J Anaesth 82:333-339
44. Wietasch JKG (2004) Pharmakologische Grundlagen moderner intravenöser Anaesthesieverfahren und ihre Bedeutung für die Steuerung der Narkosetiefe. In: Wilhelm W, Bruhn J, Kreuer S (Hrsg) Überwachung der Narkosetiefe. Grundlagen und medizinische Praxis. Deutscher Ärzteverlag, Köln, S 297-334